Molecular assays for antimalarial drug resistance surveillance: A target product profile

Christian Nsanzabana; Frederic Ariey; Hans Peter Beck; Xavier C. Ding; Edwin Kamau; Sanjeev Krishna; Eric Legrand; Naomi Lucchi; Olivo Miotto; Sidsel Nag; Harald Noedl; Cally Roper; Philip J. Rosenthal; Henk D.F.H. Schallig; Steve M. Taylor; Sarah K. Volkman; Iveth J. Gonzalez

doi:10.1371/journal.pone.0204347

Molecular assays for antimalarial drug resistance surveillance: A target product profile

Christian Nsanzabana^*, Frederic Ariey, Hans Peter Beck, Xavier C. Ding, Edwin Kamau, Sanjeev Krishna, Eric Legrand, Naomi Lucchi, Olivo Miotto, Sidsel Nag, Harald Noedl, Cally Roper, Philip J. Rosenthal, Henk D.F.H. Schallig, Steve M. Taylor, Sarah K. Volkman, Iveth J. Gonzalez

^*Corresponding author af dette arbejde

10 Citationer (Scopus)

62 Downloads (Pure)

Abstract

Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong Sub region and may emerge or spread to other malaria endemic regions. This spread is of great concern for malaria control programmes, as no alternatives to artemisinin-based combination therapies are expected to be available in the near future. There is a need to strengthen surveillance systems for early detection and response to the antimalarial drug resistance threat. Current surveillance is mainly done through therapeutic efficacy studies; however these studies are complex and both time- and resource-intensive. For multiple common antimalarials, parasite drug resistance has been correlated with specific genetic mutations, and the molecular markers associated with antimalarial drug resistance offer a simple and powerful tool to monitor the emergence and spread of resistant parasites. Different techniques to analyse molecular markers associated with antimalarial drug resistance are available, each with advantages and disadvantages. However, procedures are not adequately harmonized to facilitate comparisons between sites. Here we describe the target product profiles for tests to analyse molecular markers associated with antimalarial drug resistance, discuss how use of current techniques can be standardised, and identify the requirements for an ideal product that would allow malaria endemic countries to provide useful spatial and temporal information on the spread of resistance.

Originalsprog	Engelsk
Artikelnummer	e0204347
Tidsskrift	PLOS ONE
Vol/bind	13
Udgave nummer	9
Antal sider	18
ISSN	1932-6203
DOI	https://doi.org/10.1371/journal.pone.0204347
Status	Udgivet - 2018

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1371/journal.pone.0204347Licens: CC0

Molecular assays for antimalarial drug resistance surveillance: A target product profileForlagets udgivne version, 970 KBLicens: CC0

Citationsformater

Nsanzabana, C., Ariey, F., Beck, H. P., Ding, X. C., Kamau, E., Krishna, S., Legrand, E., Lucchi, N., Miotto, O., Nag, S., Noedl, H., Roper, C., Rosenthal, P. J., Schallig, H. D. F. H., Taylor, S. M., Volkman, S. K., & Gonzalez, I. J. (2018). Molecular assays for antimalarial drug resistance surveillance: A target product profile. PLOS ONE, 13(9), [e0204347]. https://doi.org/10.1371/journal.pone.0204347

Nsanzabana, C, Ariey, F, Beck, HP, Ding, XC, Kamau, E, Krishna, S, Legrand, E, Lucchi, N, Miotto, O, Nag, S, Noedl, H, Roper, C, Rosenthal, PJ, Schallig, HDFH, Taylor, SM, Volkman, SK & Gonzalez, IJ 2018, 'Molecular assays for antimalarial drug resistance surveillance: A target product profile', PLOS ONE, bind 13, nr. 9, e0204347. https://doi.org/10.1371/journal.pone.0204347

@article{3e7a662db65241c992a2998df5c386a0,

title = "Molecular assays for antimalarial drug resistance surveillance: A target product profile",

abstract = "Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong Sub region and may emerge or spread to other malaria endemic regions. This spread is of great concern for malaria control programmes, as no alternatives to artemisinin-based combination therapies are expected to be available in the near future. There is a need to strengthen surveillance systems for early detection and response to the antimalarial drug resistance threat. Current surveillance is mainly done through therapeutic efficacy studies; however these studies are complex and both time- and resource-intensive. For multiple common antimalarials, parasite drug resistance has been correlated with specific genetic mutations, and the molecular markers associated with antimalarial drug resistance offer a simple and powerful tool to monitor the emergence and spread of resistant parasites. Different techniques to analyse molecular markers associated with antimalarial drug resistance are available, each with advantages and disadvantages. However, procedures are not adequately harmonized to facilitate comparisons between sites. Here we describe the target product profiles for tests to analyse molecular markers associated with antimalarial drug resistance, discuss how use of current techniques can be standardised, and identify the requirements for an ideal product that would allow malaria endemic countries to provide useful spatial and temporal information on the spread of resistance.",

author = "Christian Nsanzabana and Frederic Ariey and Beck, {Hans Peter} and Ding, {Xavier C.} and Edwin Kamau and Sanjeev Krishna and Eric Legrand and Naomi Lucchi and Olivo Miotto and Sidsel Nag and Harald Noedl and Cally Roper and Rosenthal, {Philip J.} and Schallig, {Henk D.F.H.} and Taylor, {Steve M.} and Volkman, {Sarah K.} and Gonzalez, {Iveth J.}",

year = "2018",

doi = "10.1371/journal.pone.0204347",

language = "English",

volume = "13",

journal = "PLoS Computational Biology",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "9",

}

TY - JOUR

T1 - Molecular assays for antimalarial drug resistance surveillance

T2 - A target product profile

AU - Nsanzabana, Christian

AU - Ariey, Frederic

AU - Beck, Hans Peter

AU - Ding, Xavier C.

AU - Kamau, Edwin

AU - Krishna, Sanjeev

AU - Legrand, Eric

AU - Lucchi, Naomi

AU - Miotto, Olivo

AU - Nag, Sidsel

AU - Noedl, Harald

AU - Roper, Cally

AU - Rosenthal, Philip J.

AU - Schallig, Henk D.F.H.

AU - Taylor, Steve M.

AU - Volkman, Sarah K.

AU - Gonzalez, Iveth J.

PY - 2018

Y1 - 2018

N2 - Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong Sub region and may emerge or spread to other malaria endemic regions. This spread is of great concern for malaria control programmes, as no alternatives to artemisinin-based combination therapies are expected to be available in the near future. There is a need to strengthen surveillance systems for early detection and response to the antimalarial drug resistance threat. Current surveillance is mainly done through therapeutic efficacy studies; however these studies are complex and both time- and resource-intensive. For multiple common antimalarials, parasite drug resistance has been correlated with specific genetic mutations, and the molecular markers associated with antimalarial drug resistance offer a simple and powerful tool to monitor the emergence and spread of resistant parasites. Different techniques to analyse molecular markers associated with antimalarial drug resistance are available, each with advantages and disadvantages. However, procedures are not adequately harmonized to facilitate comparisons between sites. Here we describe the target product profiles for tests to analyse molecular markers associated with antimalarial drug resistance, discuss how use of current techniques can be standardised, and identify the requirements for an ideal product that would allow malaria endemic countries to provide useful spatial and temporal information on the spread of resistance.

AB - Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong Sub region and may emerge or spread to other malaria endemic regions. This spread is of great concern for malaria control programmes, as no alternatives to artemisinin-based combination therapies are expected to be available in the near future. There is a need to strengthen surveillance systems for early detection and response to the antimalarial drug resistance threat. Current surveillance is mainly done through therapeutic efficacy studies; however these studies are complex and both time- and resource-intensive. For multiple common antimalarials, parasite drug resistance has been correlated with specific genetic mutations, and the molecular markers associated with antimalarial drug resistance offer a simple and powerful tool to monitor the emergence and spread of resistant parasites. Different techniques to analyse molecular markers associated with antimalarial drug resistance are available, each with advantages and disadvantages. However, procedures are not adequately harmonized to facilitate comparisons between sites. Here we describe the target product profiles for tests to analyse molecular markers associated with antimalarial drug resistance, discuss how use of current techniques can be standardised, and identify the requirements for an ideal product that would allow malaria endemic countries to provide useful spatial and temporal information on the spread of resistance.

U2 - 10.1371/journal.pone.0204347

DO - 10.1371/journal.pone.0204347

M3 - Journal article

C2 - 30235327

AN - SCOPUS:85053676487

SN - 1932-6203

VL - 13

JO - PLoS Computational Biology

JF - PLoS Computational Biology

IS - 9

M1 - e0204347

ER -

Molecular assays for antimalarial drug resistance surveillance: A target product profile

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater